Ve. Golimbet et al., Molecular genetic polymorphism of the genes of neurotransmitter systems inschizophrenics with early manifestation of the disease, ZH NEVR PS, 101(4), 2001, pp. 48-50
Citations number
18
Categorie Soggetti
Neurology
Journal title
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA
Molecular-genetic polymorphism of genes-candidates was investigated: the ge
nes of serotonin receptor-type 2a (HTR2A), dopamine receptor gene-type 2, s
erotonin transporter (5HTTLPR). Thirty one schizophrenic patients whose age
was 12,6 +/- 3,6 years at the onset of the disease and 208 patients whose
age was 23,5 +/- 6,7 years at the onset of the disease were examined. The f
requencies of HTTLPR and DRD2 genotypes differed insignificantly in both gr
oups. The distribution of 5HTR2A genotypes in the schizophrenic group with
an early manifestation of the disease differed from that with a later manif
estation significantly (chi (2)=6,27; df=2; p=0,044). The relative risk (od
ds ratios) was 7,9 with 95% significance interval 1,008-61,94; p=0,045. The
severity of the disease and a positive family history were also examined i
n A2A2 genotype carriers. A positive family history was found in 9 (52,9%)
of the 17 schizophrenics with an early manifestation and only in 15 (21,1%)
of 71 patients of the similar group with a later one. Assessment of the cl
inical symptoms revealed that the total scores by the negative symptomatolo
gy subscale (PANSS) was higher in the patients with an early manifestation
than in those with later one; but these differences did not achieve the sig
nificance level. These and earlier findings lead to the conclusion that A2A
2 genotype was more frequently observed in the patients with more pronounce
d negative symptoms and high hereditary burden, which suggests that the A2A
2 genotype is associated with an early onset.